Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 34 35 36 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Allecra Therapeutics–Forbion: investment, 201304 financing round Series A totalling €15m incl co-lead investor Forbion 2013-04-18
Allecra Therapeutics–LCF Rothschild: investment, 201304 financing round Series A totalling €15m incl co-lead investor EdRIP 2013-04-18
Allecra Therapeutics–Orchid Chemicals: antibiotics, 201304– collab strategic partnership w Orchid Chemicals & Pharmaceuticals Ltd 2013-04-18
Allecra Therapeutics–SEVERAL: investment, 201304 financing round Series A €15m co-led by EdRIP + Forbion 2013-04-18
Bruker Corp–Univ Victoria: MS-based clinical tests, 201304– collab development iMALDI assays with UVic GBC Proteomics Centre 2013-04-18
Life Technologies–Ridom: genomic software tools, 201304– collab product integration offering SeqSphere+ bacterial typing s/w on Ion PGM sequencer 2013-04-18
Boehringer–Galapagos: drug discovery, 201304– supply drug discovery services by Argenta to respiratory target of Boehringer 2013-04-17
Lilly–Siemens: PET tracers, 201304 acquisition €na of 2 tau tangle PET tracers from Siemens Medical Solutions USA Inc 2013-04-17
Rodos BioTarget–High-Tech Gründerfonds: investment, 201304 financing round €2.6m with Enjoy Venture + HTGF + KfW ERP Start Fund + private investors 2013-04-17
Rodos BioTarget–SEVERAL: investment, 201304 financing round €2.6m from Enjoy Venture + HTGF + KfW ERP Start Fund + private investors 2013-04-17
Auris Medical–Sofinnova: investment, 201304 financing round Series C CHF47.1m from Sofinnova Ventures + Sofinnova Partners 2013-04-16
Bayer–Monsanto: plant biotechnology, 201304– cross-license agreements betw Monsanto + Bayer CropScience 2013-04-16
Charles River–Bruker Corp: mass spectrometer, 201304– supply MALDI Biotyper to be sold as part of Axcess System w Accugenix database + s/w 2013-04-15
Life Technologies–Thermo Fisher: investment, 201304–201402 acquisition $13.6b in cash $76.13/share 2013-04-15
Planet Biopharmaceuticals–Bertarelli Group: investment, 201304 acquisition 100% incl wholly-owned sub Antigen Laboratories by Ares Life Sciences 2013-04-15
Biodesix–Bruker Corp: MALDI-TOF mass spectrometry, 201304– collab + supply to support developm of MALDI-MS-based clinical diagnostic tests 2013-04-11
Eyevensys–Boehringer: investment, 201304 2nd financing round incl initial investor Boehringer Ingelheim Venture Fund 2013-04-11
Eyevensys–SEVERAL: investment, 201304– 2nd financing round with initial investor Boehringer Ingelheim Venture Fund 2013-04-11
Monsanto–Dieckmann: seeds, 201304 acquisition €na part of European business incl rape + rye seeds by Monsanto Agrar Deutschland GmbH 2013-04-11
Novaliq–Hopp Group: investment, 201304 financing round €13.9m from Dievini Hopp BioTech Holding GmbH & Co KG 2013-04-11
Panatecs–Waters: chromatography, 201304– distribution sale of Waters chromatography products via Panatecs web shop 2013-04-11
Panatecs–Waters: reagents, 201304– distribution sale of Waters analytical standards + reagents via Panatecs web shop 2013-04-11
ETG GmbH–Analytik Jena: investment, 201304 acquisition further 60% share raising Analytik Jena AG share to 80% 2013-04-10
High-Tech Gründerfonds–Lanxess: investment, 201304 investment of low 7-digit figure in High-Tech Gründerfonds II 2013-04-10
Univ Tokyo–CovalX: mass spectrometry, 201304 supply HM3 system mounted onto Axima Performance MALDI-TOF at Lab of T Kawamura 2013-04-10
CLC bio–IBM: bioinformatics, 201304 collab product integration of IBM hardware + CLC Genomics Server s/w + Workbench s/w for sequencing analytics 2013-04-09
Priaxon–Proteros: drug discovery, 201304– collab lead discovery small molecular modulators of protein-protein interaction targets 2013-04-09
Canbex Therapeutics–Merck (DE): investment, 201304 financing round totalling £2.1m incl lead investor Merck Serono Ventures 2013-04-08
Canbex Therapeutics–SEVERAL: investment, 201304 financing round £2.1m led by Merck Serono Ventures 2013-04-08
Sophia Genetics–SEVERAL: investment, 201304 financing round Series A CHF2.8m from private investors 2013-04-08
Terrain Consulting–Conway Data: investment, 201304 acquisition of Terrain Consulting Services GmbH by CDI 2013-04-08
AstraZeneca–Bayer: drug discovery, 201304– collab extension 3y mutual access to compound libraries + screening techn for selected projects 2013-04-03
Merck (DE)–BioMed X: pharma research, 201304– collab Merck Serono is 1st partner of new research project-focussed incubator concept at BioMed X 2013-04-03
UVP–Analytik Jena: investment, 201304 acquisition €na 100% of UVP LLC + wholly-owned sub Ultra-Violet Products Ltd 2013-04-02
AMR Inc–CovalX: mass spectrometry, 201304– collab distribution in Japan by AMR Inc 2013-04-01
Bio Base NWE project–EU (govt): grant, 201304– €6.2m project 50% funded by ERPD Interreg IVB North West Europe Programme 2013-04-01
CellnTec–Biognosys: MRM technology, 201304– collab offering of MRM proteomic analysis as part of skin testing services of CellnTec 2013-04-01
GeneWake–Germany (govt): grant, 201304– 2-year BMBF grant €200k to develop pharmacodx test for prostate + bladder cancer within m4 Initiative 2013-04-01
TAKTIC project–EU (govt): grant, 201304– FP7 grant €1.1m 2013-04-01
Univ Bremen–DFG (DE): grant, 201304– Core Facility grant 3 years up to €450k for MALDI-MULTI MALDI Imaging Core Facility 2013-04-01
CureVac–Russo Partners: public relations, 201303 service existent by Russo Partners LLC 2013-03-27
Medicyte–Life Technologies: lentiviral vector technology, 201303– license €na to develop + market upcyte cell products 2013-03-27
Transcatheter Technologies–High-Tech Gründerfonds: investment, 201303 financing round Series B totalling €2.6m incl returning investor HTGF 2013-03-27
Transcatheter Technologies–SEVERAL: investment, 201303 financing round Series B €2.6m lead investor Rolf Käse 2013-03-27
Innopsys–Scienion: microarray technology, 201303– collab product integration of sciFlexarrayer + InnoScan scanners to offer integrated solutions 2013-03-25
Biofrontera–Maruho: investment, 201303 capital increase €7.534m net €7.475m 1.61m new shares sold to Maruho Deutschland GmbH 2013-03-22
Partners HealthCare–Ingenuity Systems: genomic software tools, 201303– collab on integrated workflow solution for genetic testing labs GeneInsight 2013-03-19
Boehringer–HB Technologies: software solutions, 201303 supply existent Boehringer Ingelheim listed as life science customer 2013-03-18
Danaher–Leco: mass spectrometer, 201303– collab co-marketing of GC/MS + LC/MS Solutions for metabolomics in North America + Europe AB Sciex 2013-03-18
Direvo Industrial Biotechnology–SEVERAL: investment, 201303 3rd financing round €3.5m incl all current investors 2013-03-18
Eppendorf–HB Technologies: software solutions, 201303 supply existent Eppendorf listed as life science customer 2013-03-18
Eurofins–HB Technologies: software solutions, 201303 supply existent Eurofins listed as life science customer 2013-03-18
HB Technologies–Eagle Genomics: bioinformatics, 201303– collab excl distribution in DE + AT + CH + LU by HB Technologies 2013-03-18
Microsynth–HB Technologies: software solutions, 201303 supply existent Microsynth listed as life science customer 2013-03-18
Qiagen–HB Technologies: software solutions, 201303 supply existent Qiagen listed as life science customer 2013-03-18
Roche–HB Technologies: software solutions, 201303 supply existent Roche listed as life science customer 2013-03-18
Novartis–ThromboGenics: ocriplasmin, 201203– 201709 commercialisation rights for Jetrea outside US to Alcon €75m upfront + €300m ms TERMINATED 9/17 2013-03-16
Qurient–Max Planck: kinase inhibitor, 201303– license ww excl to Axl kinase inhibitors from LDC 2013-03-12
CytoTools–SEVERAL: investment, 201303 capital increase €3.7m 170k new shares €21.8/share to institutional investors 2013-03-06
Elitech–Curetis: Unyvero platform, 201303– distribution by Elitech BNL (formerly Lucron Bioproducts) in Belgium + Luxembourg 2013-03-06
Evolva–Cargill: investment, 201303 equity investment CHF5m in connection with collaboration on steviol glycosides 2013-03-06
Evolva–SEVERAL: investment, 201303 capital increase CHF31.3m with 52.2m new shares CHF0.6/share 2013-03-06
AdvanceCor–SEVERAL: investment, 201303 financing round €6.5m led by MIG AG inkl Bayern Kapital + Bio-M + HTGF + KfW Bank 2013-03-01
Harrison Clinical Research–Synteract: investment, 201303 acquisition merger €na of HCR + Synteract into SynteractHCR 2013-03-01
IFAMM project–EU (govt): grant, 201301–201702 FP7 grant €9m out of €12.25m total project cost 2013-03-01
Optimare–Aerodata: investment, 201303 acquisition €na of bankrupt Optimare Group by Aerodata AG 2013-03-01
EpiTherapeutics–Merck (DE): investment, 201302 financing round Series A 1st closing totalling €5m incl returning investor Merck Serono Ventures 2013-02-27
EpiTherapeutics–SEVERAL: investment, 201302 financing round Series A 1st closing of €5m incl Novo Seeds + MS Ventures et al. 2013-02-27
Sartorius–Aber Instruments: sensor technology, 201302– co-developm + excl ww marketing + distribution of single-use sensors to biopharma market by SSB 2013-02-27
Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201302– collab Thermo edition of established AbsoluteIDQ p150 kit for TSQ Vantage Triple Quad MS 2013-02-27
Advion–CAMAG: thin-layer chromatography, 201302– OEM distribution excl of CAMAG’s TLC/MS interface with expression CMS by Advion 2013-02-26
Leo Pharma–4SC: drug discovery services, 201302– collab €1m upfront + €95m milestones + royalties r+d + commerc drugs for inflammatory skin diseases 2013-02-26
Univ Gießen–Advion: mass spectrometer, 201302 supply existent expression CMS with CAMAG TLC/MS Interface used by Prof Gerda Morlock 2013-02-26
Ionicon–Austria (govt): grant, 201302 support funding for developm of PTR-ToF-MS for NASA project from bmvit within ASAP 8 2013-02-22
Ionicon–Univ Innsbruck: mass spectrometry, 201302 collab developm PTR-ToF-MS for NASA project 2013-02-22
United States (govt)–Ionicon: mass spectrometer, 201302 supply use of PTR-ToF-MS by NASA project to measure air pollution 2013-02-22
LUM GmbH–Germany (govt): centrifuge technology, 201302 license existent from BAM 2013-02-19
Daiichi Sankyo–Affimed: cancer antibodies, 201302– collab €na research using AbSieve discovery platform of AbCheck + U3 Pharma 2013-02-18
Roche–Chiasma: octreotide, 201302– collab developm ww excl license to commercialise Octreolin $65m upfront + $530m milestones + royalties 2013-02-18
Apeiron–Austria (govt): grant, 201302– FFG funding of up to €745k for development of APN411 2013-02-14
Boehringer–ChemAxon: cheminformatics, 201302– supply ww of ChemAxon chemistry s/w platform 2013-02-14
BioTag–Medicyte: cell technology, 201302– distribution of upcyte technology + cells in Israel by BioTag Ltd 2013-02-13
Blue Stream Laboratories–Thermo Fisher: mass spectrometer, 201302 supply purchase Thermo TSQ Vantage Triple Stage Quadrupole system 2013-02-13
MorphoSys–Heptares: therapeutic antibodies, 201302– collab strategic alliance RnD GPCR-antibodies using STaR technology + Ylanthia 2013-02-13
Westburg–Medicyte: cell technology, 201302– distribution of upcyte + vericyte technology + products in Benelux by Westburg BV 2013-02-13
Innovative Medicines Initiative–Max Planck: drug discovery, 201302– collab Lead Discovery Center GmbH is partner of European Lead Factory project 2013-02-12
B-Bridge–Pepperprint: peptide microarrays, 201302– distribution with marketing + sales rights for Pepperprint products for Japan 2013-02-08
B-Bridge–Pepperprint: peptide microarrays, 201302– distribution with marketing + sales rights for Pepperprint products for North America 2013-02-08
Apogenix–MC Services: public relations, 201302 service existent for Apogenix GmbH 2013-02-07
Ono Pharmaceutical–Genedata: mass spectrometry s/w, 201302– license to Genedata Expressionist for Mass Spectrometry 2013-02-07
Merck (DE)–Opexa Therapeutics: imilecleucel-T, 201302– option for excl license developm + commerc of Tcelna for MS ww excl JP $5m upfront 2013-02-05
Sopat–High-Tech Gründerfonds: investment, 201302 1st financing round HTGF + Steelhouse Ventures Ltd 2013-02-04
Sopat–SEVERAL: investment, 201302 1st financing round HTGF + Steelhouse Ventures Ltd 2013-02-04
Spain (govt)–Scienion: print/spotting technology, 201302 supply use of sciFlexarrayer to produce nanobiosensors by Bionanomechanics Lab at IMM-CSIC 2013-02-04
Dynamic Biosensors–SEVERAL: investment, 201302 1st financing round Bayern Kapital + BioM + Extorel + TUM-Fonds 2013-02-01
Epigenomics–Van Lanschot: investment, 201302 DIVESTMENT F van Lanschot Bankiers NV sells all 26.32% shares owned 2013-02-01
Innovative Medicines Initiative–Bayer: drug discovery, 201302– collab Bayer HealthCare is coordinating partner of European Lead Factory project 2013-02-01
Innovative Medicines Initiative–EU (govt): grant, 201302– funding support €80m for European Lead Factory project via FP7 2013-02-01
PharmaSea project–EU (govt): grant, 201302–201701 FP7 grant €9.5m 2013-02-01
Epigenomics–Abingworth: investment, 201301 existent Abingworth Bioventures V owns 14.43% of voting rights 2013-01-29
next pagenext page 1 2 3 ... 34 35 36 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top